It is phase 2 results of acne that will light the fire. That in itself is huge but then people will fully appreciate the dermatitis angle.
It will be about education for a multi billion dollar market category changer.
Getting to 20c last year did not make me sell a single share either.
Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received, page-109
-
- There are more pages in this discussion • 89 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.010(2.82%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.0¢ | 34.0¢ | $670.1K | 1.913M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 252957 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 204858 | 10 |
View Market Depth
| Last trade - 14.39pm 27/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
